Marta Isasa

Marta Isasa is a prominent scientist specializing in biological sciences and proteomics technologies. She currently serves as the Associate Director of Chemical Biology and Proteomics at Stealth NewCo, a stealth biotech company focused on innovative therapeutic developments. Before this role, she was the Head of the Proteomics Core Unit at the Spanish National Center for Cancer Research (CNIO) since October 2022.1

Education and Early Career

Marta completed her undergraduate degree in Organic Chemistry at the Chemical Institute of Sarrià (IQS) - Ramon Llull University, followed by a Master's in Biomedical Research at the University of Barcelona. She earned her Ph.D. in Biomedicine from the University of Barcelona, focusing on proteasome regulation mechanisms.1

Professional Experience

• Postdoctoral Fellow: Marta conducted research at Harvard Medical School under Professor Steven Gygi, a leader in mass spectrometry-based proteomics.
• Research Scientist: At C4 Therapeutics, she integrated her interests in ubiquitin cell signaling and proteomics into targeted protein degradation strategies.
• Previous Position: Before joining Stealth NewCo, she was the Associate Director at Odyssey Therapeutics from September 2021 to October 2022.1

Contributions and Interests

Marta is not only dedicated to research but also engages in science communication through local media and has a strong interest in teaching. Her work primarily involves developing analytical methods for proteomics and identifying disease biomarkers.1